1. Home
  2. CCCC vs PDLB Comparison

CCCC vs PDLB Comparison

Compare CCCC & PDLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$3.73

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

Logo Ponce Financial Group Inc.

PDLB

Ponce Financial Group Inc.

HOLD

Current Price

$20.07

Market Cap

481.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCCC
PDLB
Founded
2015
1960
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
404.7M
481.1M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
CCCC
PDLB
Price
$3.73
$20.07
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$12.20
N/A
AVG Volume (30 Days)
2.6M
59.7K
Earning Date
05-06-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
16.45
160.87
EPS
N/A
0.71
Revenue
$35,947,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$28.38
Revenue Growth
1.02
N/A
52 Week Low
$1.69
$13.91
52 Week High
$5.17
$20.79

Technical Indicators

Market Signals
Indicator
CCCC
PDLB
Relative Strength Index (RSI) 47.01 51.76
Support Level $3.42 $19.49
Resistance Level $3.91 $20.68
Average True Range (ATR) 0.22 0.47
MACD 0.00 -0.02
Stochastic Oscillator 47.46 50.00

Price Performance

Historical Comparison
CCCC
PDLB

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

Share on Social Networks: